Mitoxantrone Hydrochloride Liposome Injection, Bortezomib and Dexamethasone in the Treatment of R/R MM
Clinical trial NCT05052970 · UNKNOWN
Trial details
- NCT number
- NCT05052970
- Sponsor
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-20
- Primary completion
- 2023-04-20
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.